Keeping a lid on drug prices is proving costly for ambitions to turn the UK into a life sciences superpower ...

The UK announced the funding at the AI Action Summit in Paris where it abstained from signing a declaration on an inclusive ...

Despite the death of its golden goose, AbbVie expects to achieve high single-digit compound annual sales growth to the end of ...

In addition to the UK investment controversy, AstraZeneca is also dealing with legal challenges in China. The company ...

CEO Richard Francis reflects on Teva’s return to growth during his tenure, and what’s next for the drugmaker in its quest to ...

The pharmaceutical industry is bracing for potentially major disruptions following US President Donald Trump’s announcement ...

Glenmark Pharmaceuticals receives UK approval for Winlevi, a groundbreaking topical acne treatment with unique mechanism of ...

Trump's tariffs will not only impact sponsors, but higher costs will ripple down the clinical trial supply chain in the US.

Pharma giant AstraZeneca urged Britain to improve the environment for businesses in order to drive investment, days after it ...

As Donald Trump wields the threat of tariffs on EU and even UK goods, which industries would be worst affected and could the ...

The UK currently has some additional reporting ... As such, observational research provides an important means for pharma companies to assess the effectiveness and proper use of medicinal products ...

Insider has named its second batch of choices for the most promising younger businesses in Yorkshire.